超分子化学
分子间力
小分子
分子
纳米技术
神经毒性
材料科学
选择性
手性(物理)
分子识别
组合化学
化学
对映选择合成
组分(热力学)
分子间相互作用
肽
疾病
作者
Zixuan Zhang,Kunyi Wang,Xuefan Guo,Guoyang Zhang,Yulong Jin,Zhuo Wang
摘要
ABSTRACT Abnormal aggregation of amyloid‐β (Aβ) peptides is a central pathological event in Alzheimer's disease (AD), closely associated with neurotoxicity and disease progression. The development of molecules or materials with high selectivity and affinity toward Aβ aggregates constitutes an essential component for the early diagnosis and intervention of AD. Aβ peptides, composed of homochiral amino acids, undergo intermolecular β‐sheet assembly to form supramolecular chiral aggregates, providing a structural basis for chirality‐sensitive recognition. Therefore, chiral materials have attracted significant attention in Aβ aggregates recognition and regulation. Previous reviews have examined different types of chiral materials for the inhibition of Aβ aggregation, including chiral small molecules, amino acids, peptides, and various chiral interfaces or nanomaterials. The present review organizes reported chiral materials according to three intervention strategies for modulating Aβ aggregation: conformation‐locking, self‐assembly‐induced remodeling, and multifunctional intervention. We summarize representative materials in each category, along with the corresponding design principles and modulation performance toward Aβ aggregation. Current challenges and potential directions for the development of chiral therapeutics for AD are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI